Prognostic assessment should incorporate the IPI, which has been adapted for PTCLs, alongside the prognostic index for PTCL-NOS (PIT) and its modified version including Ki-67 expression. The gene discussed is MKI67; the disease is mature T-cell and NK-cell non-Hodgkin lymphoma.